
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Armenian White Mulberry (Morus alba) contains 1-deoxynojirimycin (DNJ) which inhibits alpha-glucosidase and maltase-glucoamylase enzymes to regulate postprandial glucose levels. The berries deliver quercetin 3-O-rutinoside at 71.1±4.8 mg/100g alongside other flavonoids that modulate ADORA1 and PPARγ pathways for metabolic support.

Reported Benefits (Provisional)
Origin & History

The Armenian White Mulberry, Morus alba, is native to the mountainous regions of Armenia, thriving in temperate climates with well-drained, fertile soils. This fruit is recognized for its delicate flavor and rich profile of bioactive compounds, offering functional nutritional benefits.
Research Narrative (Provisional)
Research confirms the antioxidant properties of white mulberries, with studies indicating potential benefits for cardiovascular health, immune support, and skin rejuvenation. Further investigation is ongoing to fully characterize these effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C, Vitamin K - Minerals: Iron, Calcium - Phytochemicals/Bioactives: Flavonoids
Reported Mechanism (Provisional)
The primary bioactive compound 1-deoxynojirimycin (DNJ) inhibits alpha-glucosidase, maltase-glucoamylase (MGAM), and sucrase-isomaltase (SI) enzymes to control carbohydrate metabolism and reduce postprandial glucose spikes. Flavonoids including morusin, kuwanon C, and morusyunnansin L target ADORA1 and PPARγ receptors to improve insulin sensitivity. The ethanolic extracts reduce NF-κB activation and suppress proinflammatory cytokines IL-1β, IL-6, and TNF-α while modulating the BDNF/TrkB pathway for neuroprotection.
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and cell line studies rather than human clinical trials. Research shows ethanolic extracts at 20-40 mg/mL inhibited nitric oxide production in LPS-stimulated RAW264.7 macrophages, while the JS-MP-1 glycoprotein enhanced B and T cell proliferation at concentrations of 125-2000 µg/mL. Enzyme-assisted extraction methods achieved 76% recovery of phytochemicals compared to 12% with traditional homogenization methods. Human clinical trials with specific dosages and outcomes are needed to validate the preliminary laboratory findings.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







